These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 18209487

  • 1. Influence of atenolol and nifedipine on nitric-oxide deficient cardiomyocyte hypertrophy and expression of the cardio-endocrine peptide intermedin and its receptor components.
    Bell D, Zhao YY, Devine AB, McDermott BJ.
    Cell Physiol Biochem; 2008; 21(1-3):203-14. PubMed ID: 18209487
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
    Zhao Y, Bell D, Smith LR, Zhao L, Devine AB, McHenry EM, Nicholls DP, McDermott BJ.
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1269-81. PubMed ID: 16326922
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of an anti-oxidant intervention on cardiomyocyte expression of adrenomedullin and intermedin and their receptor components in chronic nitric oxide deficiency.
    Bell D, Zhao Y, McCoy FP, Devine AB, McDermott BJ.
    Cell Physiol Biochem; 2007 Mar; 20(5):269-82. PubMed ID: 17762156
    [Abstract] [Full Text] [Related]

  • 4. Adrenomedullin gene delivery is cardio-protective in a model of chronic nitric oxide deficiency combining pressure overload, oxidative stress and cardiomyocyte hypertrophy.
    Bell D, Campbell M, Wang X, Earle JA, Cosby SL, McDermott BJ.
    Cell Physiol Biochem; 2010 Mar; 26(3):383-94. PubMed ID: 20798523
    [Abstract] [Full Text] [Related]

  • 5. Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes.
    Bell D, Zhao Y, McCoy FP, Devine A, McDermott BJ.
    Cell Physiol Biochem; 2008 Mar; 21(5-6):409-20. PubMed ID: 18453748
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of adrenomedullin and its receptor components during cardiomyocyte hypertrophy induced by chronic inhibition of nitric oxide synthesis in rats.
    Bell D, Zhao YY, Kelso EJ, McHenry EM, Rush LM, Lamont VM, Nicholls DP, McDermott BJ.
    Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H904-14. PubMed ID: 16040721
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat.
    Pan ChS, Jiang W, Wu ShY, Zhao J, Pang YZ, Tang ChS, Qi YF.
    Basic Res Cardiol; 2006 May; 101(3):193-203. PubMed ID: 16450076
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
    Hiragushi K, Wada J, Eguchi J, Matsuoka T, Yasuhara A, Hashimoto I, Yamashita T, Hida K, Nakamura Y, Shikata K, Minamino N, Kangawa K, Makino H.
    Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The myocardial response to adrenomedullin involves increased cAMP generation as well as augmented Akt phosphorylation.
    Pan CS, Jin SJ, Cao CQ, Zhao J, Zhang J, Wang X, Tang CS, Qi YF.
    Peptides; 2007 Apr; 28(4):900-9. PubMed ID: 17306419
    [Abstract] [Full Text] [Related]

  • 14. Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension.
    Tadokoro K, Nishikimi T, Mori Y, Wang X, Akimoto K, Matsuoka H.
    Regul Pept; 2003 Apr 15; 112(1-3):71-8. PubMed ID: 12667627
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of ligand, receptor system, and amidating activity of adrenomedullin in left ventricular hypertrophy of severely hypertensive rats: effects of angiotensin-converting enzyme inhibitors and diuretic.
    Wang X, Nishikimi T, Akimoto K, Tadokoro K, Mori Y, Minamino N.
    J Hypertens; 2003 Jun 15; 21(6):1171-81. PubMed ID: 12777955
    [Abstract] [Full Text] [Related]

  • 16. Adrenomedullin and its receptor components in adipose tissues: Differences between white and brown fats and the effects of adrenergic stimulation.
    Go AG, Chow KH, Hwang IS, Tang F.
    Peptides; 2007 Apr 15; 28(4):920-7. PubMed ID: 17250927
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Involvement of vascular endothelial growth factor signaling in CLR/RAMP1 and CLR/RAMP2-mediated pro-angiogenic effect of intermedin on human vascular endothelial cells.
    Albertin G, Sorato E, Oselladore B, Mascarin A, Tortorella C, Guidolin D.
    Int J Mol Med; 2010 Aug 15; 26(2):289-94. PubMed ID: 20596610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.